Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1992-04-20
1993-05-18
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514877, A61K 3122
Patent
active
052122026
ABSTRACT:
A method and apparatus are disclosed for treating a patient having cholesterol calculi which involves infusing into the biliary tract of said patient a C.sub.5 -C.sub.6 ester having a boiling point in the range of 80.degree.-140.degree. C. in an amount and at a flow rate effective to at least partially dissolve said calculi rapidly. It is found that the ester has little or no tendency to accumulate in the blood stream when perfused into a patient, particular as compared to methyl t-butyl ether (MTBE), the solvent widely used at present. The invention also encompasses dissolving cholesterol calculi by exposing such calculi to contact with effective quantities of those solvent compounds. The method preferably uses a high flow rate catheter pumping system for infusing a gallstone dissolution solvent into the gallbladder of a patient and aspirating the gallstone dissolution solvent from the gallbladder, and a unit measure container of the solvent. The preferred esters are n-propyl acetate, isopropyl acetate, ethyl propionate and ethyl isobutyrate, with ethyl propionate being the most preferred. Contact flow rates are sufficiently high to insure fluid turbulence in the biliary tract region surrounding the calculi.
REFERENCES:
patent: 4205086 (1980-05-01), Babayan
patent: 4758596 (1988-07-01), Thistle et al.
patent: 4902276 (1990-02-01), Zakko
patent: 4910223 (1990-03-01), Hofmann
Takasawa et al., "A Study on the Dissolution . . . ", Tohoku J. Exp. Med., 138, 383-395 (1982).
Leuschner et al., "Alternating Treatment . . . ", Scand. J. Gastroent., 16, 497-503 (1981).
Leuschner et al., "Gallstone Dissolution . . . ", Amer. J. Gastroent., 77, 4, 222-226 (1982).
Lueschner et al., "Biochemical and Morphological . . . ", Amer. J. Gastroent., 79, 4, 291-298 (1984).
Motson, "Dissolution of Common . . . ", Br. J. Surg., 68, 203-208 (1981).
Leuschner et al., "Investigations on the Toxicity . . . ", Digestion, 30, 23-32 (1984).
Carey et al., "Cholelithiasis and Cholecystitis", in Conn, ed., Current Therapy 1981, 364-366 (1981).
Allen et al., "Cholelitolysis Using . . . ", Gastroenterology, 88, 122-125 (1985).
Allen et al., "Rapid Dissolution . . . ", N. Eng. J. Med., 312, 4, 217-220 (1985).
Ponz de Leon et al., "The Effect of Dihydroxydibutylether . . . ", Intl. J. Clin. Pharm., Ther. and Toxicol., 21, 1, 37-40 (1983).
Missale et al., "Effect of Dihydroxydibutylether . . . ", Int. J. Clin. Pharm. Ther. and Toxicol., 19, 6, 273-274 (1981).
Sama et al., "A Double-Blind Comparison . . . ", Intl. J. Clin. Pharm., Ther. and Toxicol., 21, 2, 95-97 (1983).
Leuschner et al., "Dissolution of Bileduct Stones", The Lancet, 336 (Feb. 7, 1981).
Leuschner et al., "The Dissolution of CBD Cholesterol . . . ", Gastroenterology, 88, 5, 1674 (1985).
Leuschner et al., "Our 10 Years' Experience . . . ", Gastroenterology, 82, 5, 1113 (1982).
Allen et al., Abstract No. 44, "Methyl Tertiary Butyl Ether . . . " and Abstract No. 45, Gallstone Dissolution . . . , Hepatology, 3, 5, 809 (1983).
Bugliosi et al., "Rapid Gallstone Dissolution . . . " Gastroenterology, 86, 5, 1350 (1984).
Buliosi et al., "Methyl Tertiary-Butyl Ether (MTBE) . . . ", Gastroenterology, 86, 5, 1313 (1984).
Hofmann Alan F.
Schteingart Claudio D.
Henley III Raymond J.
The Regents of the University of California
Waddell Frederick E.
LandOfFree
Therapeutic cholesterol gallstone dissolution method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic cholesterol gallstone dissolution method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic cholesterol gallstone dissolution method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-804789